Literature DB >> 2322900

Inhibitory innervation of colonic smooth muscle cells and interstitial cells of Cajal.

J D Huizinga1, I Berezin, E E Daniel, E Chow.   

Abstract

The effect of neural inhibition on the electrical activities of circular and longitudinal colonic smooth muscle was investigated. In addition, a comparative study was carried out between circular muscle preparations with and without the "submucosal" and "myenteric plexus" network of interstitial cells of Cajal (ICC) to study innervation of the "submucosal" ICC and to investigate whether or not the ICC network is an essential intermediary system for inhibitory innervation of smooth muscle cells. Electrical stimulation of intrinsic nerves in the presence of atropine caused inhibitory junction potentials (ijps) throughout the circular and longitudinal muscle layers. The ijp amplitude depended on the membrane potential and not on the location of the muscle cells with respect to the ICC network. Neurally mediated inhibition of the colon resulted in a reduction in amplitude and duration of slow wave type action potentials in circular and abolishment of spike-like action potentials in longitudinal smooth muscle, both resulting in a reduction of contractile activity. With respect to mediation by ICC, the study shows (i) "submucosal" ICC receive direct inhibitory innervation and (ii) circular smooth muscle cells can be directly innervated by inhibitory nerves without ICC as necessary intermediaries. The reversal potential of the ijp in colonic smooth muscle was observed to be approximately -76 mV, close to the estimated potassium equilibrium potential, suggesting that the nerve-mediated hyperpolarization is caused by increased potassium conductance.

Entities:  

Mesh:

Year:  1990        PMID: 2322900     DOI: 10.1139/y90-063

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  12 in total

Review 1.  Interstitial cells of Cajal in enteric neurotransmission.

Authors:  S M Ward
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Inhibitory effect of schisandrin on spontaneous contraction of isolated rat colon.

Authors:  Jiaming Yang; Paul S P Ip; John H K Yeung; Chun-Tao Che
Journal:  Phytomedicine       Date:  2011-04-21       Impact factor: 5.340

Review 3.  Intercellular communication in smooth muscle.

Authors:  J D Huizinga; L W Liu; M G Blennerhassett; L Thuneberg; A Molleman
Journal:  Experientia       Date:  1992-10-15

4.  Use of rhodamine 123 to label and lesion interstitial cells of Cajal in canine colonic circular muscle.

Authors:  S M Ward; E P Burke; K M Sanders
Journal:  Anat Embryol (Berl)       Date:  1990

Review 5.  Physiology and pathophysiology of colonic motor activity (1).

Authors:  S K Sarna
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

6.  Purinergic mechanisms in the control of gastrointestinal motility.

Authors:  J C Bornstein
Journal:  Purinergic Signal       Date:  2007-10-06       Impact factor: 3.765

7.  Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.

Authors:  Maria M Buckley; Ken D O'Halloran; Mark G Rae; Timothy G Dinan; Dervla O'Malley
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

8.  Identification and classification of interstitial cells in the canine proximal colon by ultrastructure and immunocytochemistry.

Authors:  S Torihashi; W T Gerthoffer; S Kobayashi; K M Sanders
Journal:  Histochemistry       Date:  1994-03

9.  Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.

Authors:  Y M Qian; R L Jones
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

10.  Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition.

Authors:  S J Middleton; A W Cuthbert; M Shorthouse; J O Hunter
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.